These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2959242)

  • 41. Structure and function of human complement receptors: 1985.
    Gresham HD; Volanakis JE
    Year Immunol; 1986; 2():177-86. PubMed ID: 2883788
    [No Abstract]   [Full Text] [Related]  

  • 42. Decreased expression of the C3b/C4b complement receptor (CR1) in AIDS and AIDS-related syndromes correlates with clinical subpopulations of patients with HIV infection.
    Jouvin MH; Rozenbaum W; Russo R; Kazatchkine MD
    AIDS; 1987 Jul; 1(2):89-94. PubMed ID: 2966632
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Clinical significance of C3 receptors (CR1, 2, 3, 4) analysis].
    Seya T; Uenaka A; Matsumoto M; Kitamura H
    Nihon Rinsho; 1990 Feb; 48 Suppl():641-6. PubMed ID: 2192160
    [No Abstract]   [Full Text] [Related]  

  • 44. Erythrocyte C4d and complement receptor 1 in systemic lupus erythematosus.
    Singh V; Mahoney JA; Petri M
    J Rheumatol; 2008 Oct; 35(10):1989-93. PubMed ID: 18709693
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Human C5a modulates monocyte Fc and C3 receptor expression.
    Yancey KB; O'Shea J; Chused T; Brown E; Takahashi T; Frank MM; Lawley TJ
    J Immunol; 1985 Jul; 135(1):465-70. PubMed ID: 3158706
    [TBL] [Abstract][Full Text] [Related]  

  • 46. C3b receptor (CR1) on erythrocytes and the HLA-DR3 antigen.
    Malaise M; Desoroux A; Mahieu P; Franchimont P
    Arthritis Rheum; 1986 Feb; 29(2):300-1. PubMed ID: 2937410
    [No Abstract]   [Full Text] [Related]  

  • 47. The relative roles of genetic and environmental factors in the regulation of erythrocyte C3b receptor (ECR1) numbers in normal individuals.
    Fyfe A; Holme ER; McKay IC; Zoma A; Hunter J; Lucie NP; Whaley K
    Clin Exp Immunol; 1987 Oct; 70(1):231-7. PubMed ID: 2961490
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immune complexes and erythrocyte CR1 (complement receptor type 1): effect of CR1 numbers on binding and release reactions.
    Ng YC; Schifferli JA; Walport MJ
    Clin Exp Immunol; 1988 Mar; 71(3):481-5. PubMed ID: 2968204
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The complement-mediated binding of soluble antibody/dsDNA immune complexes to human neutrophils.
    Taylor RP; Burge J; Horgan C; Shasby DM
    J Immunol; 1983 Jun; 130(6):2656-62. PubMed ID: 6854016
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immune complex clearance by complement receptor type 1 in SLE.
    Kavai M
    Autoimmun Rev; 2008 Dec; 8(2):160-4. PubMed ID: 18602499
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Reduced complement receptor 1 (CR1, CD35) transcription in systemic lupus erythematosus.
    Arora V; Verma J; Dutta R; Marwah V; Kumar A; Das N
    Mol Immunol; 2004 Jun; 41(4):449-56. PubMed ID: 15163541
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Complement receptor 1 (CD35) on human reticulocytes: normal expression in systemic lupus erythematosus and HIV-infected patients.
    Lach-Trifilieff E; Marfurt J; Schwarz S; Sadallah S; Schifferli JA
    J Immunol; 1999 Jun; 162(12):7549-54. PubMed ID: 10358211
    [TBL] [Abstract][Full Text] [Related]  

  • 53. CR1 density polymorphism and expression on erythrocytes of patients with systemic lupus erythematosus.
    Kiss E; Csipö I; Cohen JH; Reveil B; Kávai M; Szegedi G
    Autoimmunity; 1996; 25(1):53-8. PubMed ID: 9161700
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Studies on immune adherence (C3b) receptor activity of human erythrocytes: relationship between receptor activity and presence of immune complexes in serum.
    Inada Y; Kamiyama M; Kanemitsu T; Hyman CL; Clark WS
    Clin Exp Immunol; 1982 Oct; 50(1):189-97. PubMed ID: 6216998
    [TBL] [Abstract][Full Text] [Related]  

  • 55. CR1 activity on erythrocytes and renal glomeruli in patients with renal disorders.
    Iversen BM; Vedeler CA; Matre R; Svarstad E
    Nephrol Dial Transplant; 1993; 8(11):1211-4. PubMed ID: 8302457
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification of complement receptor type 1-related proteins on primate erythrocytes.
    Nickells MW; Subramanian VB; Clemenza L; Atkinson JP
    J Immunol; 1995 Mar; 154(6):2829-37. PubMed ID: 7876553
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CR1 and the cell membrane proteins that bind C3 and C4. A basic and clinical review.
    Wilson JG; Andriopoulos NA; Fearon DT
    Immunol Res; 1987; 6(3):192-209. PubMed ID: 2960763
    [No Abstract]   [Full Text] [Related]  

  • 58. The frequency of complement receptor type 1 (CR1) gene polymorphisms in nine families with multiple cases of systemic lupus erythematosus.
    Tebib JG; Martinez C; Granados J; Alarcon-Segovia D; Schur PH
    Arthritis Rheum; 1989 Nov; 32(11):1465-9. PubMed ID: 2573360
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Does reduced erythrocyte C3b receptor (CR1) activity contribute to the pathogenesis of yersinia triggered reactive arthritis?
    Lahesmaa R; Eerola E; Toivanen A
    Ann Rheum Dis; 1992 Jan; 51(1):97-100. PubMed ID: 1531747
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Quantitative analyses of the binding of soluble complement-fixing antibody/dsDNA immune complexes to CR1 on human red blood cells.
    Edberg JC; Wright E; Taylor RP
    J Immunol; 1987 Dec; 139(11):3739-47. PubMed ID: 2960742
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.